DALLANOCE, CLELIA MARIANGIOLA LUISA
 Distribuzione geografica
Continente #
EU - Europa 10.600
NA - Nord America 9.137
AS - Asia 8.143
SA - Sud America 785
AF - Africa 218
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.985
Nazione #
US - Stati Uniti d'America 8.861
IT - Italia 2.512
SG - Singapore 2.327
CN - Cina 2.302
GB - Regno Unito 2.259
DE - Germania 1.848
RU - Federazione Russa 1.057
SE - Svezia 907
HK - Hong Kong 736
BR - Brasile 583
BD - Bangladesh 553
FR - Francia 511
IN - India 502
VN - Vietnam 461
KR - Corea 286
NL - Olanda 269
IE - Irlanda 248
TR - Turchia 242
FI - Finlandia 204
JP - Giappone 185
CA - Canada 166
UA - Ucraina 157
ES - Italia 146
ID - Indonesia 126
DK - Danimarca 118
AU - Australia 85
EU - Europa 81
CI - Costa d'Avorio 60
PK - Pakistan 55
MX - Messico 52
PH - Filippine 51
CH - Svizzera 50
AR - Argentina 49
CO - Colombia 49
BE - Belgio 46
AT - Austria 44
IR - Iran 41
TW - Taiwan 40
ZA - Sudafrica 40
IQ - Iraq 37
PL - Polonia 37
CL - Cile 35
GR - Grecia 33
EC - Ecuador 31
RO - Romania 30
MA - Marocco 24
MY - Malesia 24
UZ - Uzbekistan 23
TH - Thailandia 22
EG - Egitto 21
IL - Israele 21
KE - Kenya 21
SA - Arabia Saudita 21
NO - Norvegia 15
CZ - Repubblica Ceca 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
AL - Albania 12
JM - Giamaica 12
PT - Portogallo 11
NP - Nepal 10
HU - Ungheria 9
LU - Lussemburgo 9
PR - Porto Rico 9
RS - Serbia 9
VE - Venezuela 9
BY - Bielorussia 8
PY - Paraguay 8
UY - Uruguay 8
JO - Giordania 7
KG - Kirghizistan 7
LK - Sri Lanka 7
PE - Perù 7
SC - Seychelles 7
BB - Barbados 6
BH - Bahrain 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
HN - Honduras 6
KW - Kuwait 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CM - Camerun 5
CR - Costa Rica 5
DZ - Algeria 5
HR - Croazia 5
LT - Lituania 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
GT - Guatemala 3
LB - Libano 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
PA - Panama 3
PF - Polinesia Francese 3
SV - El Salvador 3
TZ - Tanzania 3
Totale 29.010
Città #
Southend 1.980
Singapore 1.361
Ashburn 880
Hanover 828
Milan 787
Hong Kong 667
Dallas 657
San Jose 657
Chandler 605
Beijing 465
Council Bluffs 420
Seattle 329
Princeton 302
Santa Clara 267
Dublin 237
Los Angeles 229
Wilmington 229
Munich 209
Rome 204
Ann Arbor 184
New York 173
Hefei 154
Mountain View 148
Ho Chi Minh City 144
Bengaluru 139
Lauterbourg 139
Boardman 131
Frankfurt am Main 130
Fairfield 128
Dearborn 123
Moscow 121
Buffalo 119
Redmond 113
Hanoi 112
Nanjing 109
Des Moines 103
Houston 102
Woodbridge 102
Berlin 93
Jakarta 91
Guangzhou 88
Tokyo 84
Shanghai 76
The Dalles 75
Seoul 74
Cambridge 70
Redwood City 67
Barcelona 62
Jinan 62
Abidjan 60
Helsinki 60
São Paulo 59
Toronto 59
Jacksonville 57
Columbus 56
Sakarya 54
Medford 53
Naples 53
Somerville 52
Würzburg 50
Shenyang 49
Tianjin 49
Cangzhou 46
Istanbul 46
Atlanta 41
Hangzhou 41
Brescia 40
Andover 39
Stockholm 39
San Diego 38
Changsha 37
Amsterdam 36
London 36
Bogotá 35
Brussels 34
Mumbai 34
Serra 34
Turin 34
Chicago 33
Nanchang 32
Florence 31
Nuremberg 31
Orem 31
Kent 29
Melbourne 29
Zhengzhou 29
Eitensheim 28
Phoenix 28
Piscataway 28
Athens 27
Hebei 27
Denver 25
Irvine 25
Ningbo 25
San Francisco 25
Bühl 24
Montreal 24
Fuzhou 23
Haiphong 23
Lappeenranta 23
Totale 16.550
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 675
Agonisti nicotinici selettivi nel trattamento di patologie del Sistema Nervoso Centrale 607
Epiboxidine and Novel Related Analogues : a Convenient Synthetic Approach and Estimation of Their Affinity at Neuronal Nicotinic Acetylcholine Receptor Subtypes 525
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors 449
Combined treatments with the dualsteric agonist N-8-Iper plus chemotherapy drugs affect drug resistance in glioblastoma cancer stem cells 439
Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes 377
Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype [Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the alpha 3 beta 4 nicotinic acetylcholine receptor subtype] 329
A convenient synthesis of 4-(2-hydroxyethyl)indolin-2-one, a useful intermediate for the preparation of both dopamine receptor agonists and protein kinase inhibitors 318
The Mechanisms Mediated by α7 Acetylcholine Nicotinic Receptors May Contribute to Peripheral Nerve Regeneration 306
Selective agonists for M2 muscarinic receptors inhibit cell proliferation and survival in human glioblastoma cells: Possible implications in drug resistance 292
Chimica Analitica e Analisi Quantitativa 285
Photoswitchable ligands for the optical control of α7 nicotinic acetylcholine receptors: synthesis and photochromic characterization 281
New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: Synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations 280
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activity 280
Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors 270
Synthesis and characterization of 13C labeled carnosine derivatives for isotope dilution mass spectrometry measurements in biological matrices 270
The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling 267
Orthosteric and allosteric ligands selectively acting at cholinergic receptor subtypes 258
Synthesis of epibatidine-related Delta(2)-isoxazoline derivatives and evaluation of their binding affinity at neuronal nicotinic acetylcholine receptors 256
Synthesis and application of isotope-labeled carnosine in LCMS/MS 256
Novel pharmacological tools which activate mAChRs: a question of "dualsterism" 251
Design, Synthesis, and Pharmacological Characterization of Novel Spirocyclic Quinuclidinyl-Δ2-Isoxazoline Derivatives as Potent and Selective Agonists of α7 Nicotinic Acetylcholine Receptors 250
Dualsteric compounds modulate the signaling pattern of muscarinic M1 acetylcholine receptors 246
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 245
Synthesis of novel chiral Δ2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes 243
Interaction between M2 Muscarinic receptors and β-1 arrestin in gliblastoma cell lines: effects mediated by orthosteric and dualsteric agonists 242
Iperoxo/dequalinium and W84/dequalinium hybrid ligands: synthesis, pharmacological and computational investigation at M2 mAChRs 241
Novel ligands for neuronal nicotinic receptor subtypes: synthetic, pharmacological and molecular docking studies 237
Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation 233
Allosteric modulation of alpha7 nicotinic receptors : mechanistic insight through metadynamics and essential dynamics 227
The enantiomers of epiboxidine and of two related analogs: Synthesis and estimation of their binding affinity at α4β2 and α7 neuronal nicotinic acetylcholine receptors 225
The impact of Chirality on Medicinal Chemistry 224
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system 223
Optical control of dopamine receptors in vitro and in vivo with photoswitchable ligands 220
7'-Aminonaphthazarin antibiotic derivatives 219
Design and synthesis of selective ligands targeting different nAChR subtypes 219
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors 217
(Trans)dermal delivery of opioids: a structure-permeability relationship 217
Epiboxidine and Novel-Related Analogues: A Convenient Synthetic Approach and Estimation of Their at Neuronal Nicotinic Acetylcholine Receptor Subtypes 217
Identification of novel potential B4GALT6 inhibitors through a large scale virtual screening 216
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: Synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 216
Determination of acid dissociation constants of compounds active at neuronal nicotinic acetylcholine receptors by means of electrophoretic and potentiometric techniques 216
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 216
New spirocyclic Δ2-isoxazoline derivatives related to selective agonists of α7 neuronal nicotinic acetylcholine receptors 215
Determination of acid dissociation constants of poorly water-soluble nicotinic ligands by means of electrophoretic and potentiometric techniques 215
Design, synthesis and preliminary biological evaluation of 3-cyclopropyl-4-phenoxy-1H-pyrazole derivatives as small molecular ligands of RAGE 213
Activation Effects of Carnosine- and Histidine-Containing Dipeptides on Human Carbonic Anhydrases: A Comprehensive Study 212
Alpha7 nAChR: pathogenesis and treatment of chemotherapy-induced neuropathy 210
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization 210
Design of novel α7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies 207
Nuovi ligandi nicotinici correlati all'Epibatidina e all'Epibossidina: sintesi e valutazione della loro affinità per i recettori nicotinici neuronali alpha4beta2 e alpha7 207
In silico design of agonists targeting the alpha7 nicotinic acetylcholine receptors, their synthesis and preliminary pharmacological evaluation 206
Peptide derivatives and therapeutic activity thereof 204
Modulation of the D3R-nAChR Heteromeric Complex Attenuates Nicotine Self-Administration 204
The enantiomers of epiboxidine: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes 201
Chemotherapy-induced neuropathy: involvement of the alpha7 nAChR subtype 201
Allosteric ligands for G protein-coupled receptors : a novel strategy with attractive therapeutic opportunities 200
Tacrine/Xanomeline hybrid ligands: synthesis and pharmacological evaluation at M1 muscarinic acetylcholine receptors and acetylcholinesterases 200
Photoswitchable ligands for light-mediated control of α7 nicotinic acetylcholine receptors: design, synthesis and photochromic characterization 197
A Photoactivatable Version of Ivabradine Enables Light-Induced Block of HCN Current In Vivo 196
Novel spirocyclic delta2-isoxazoline derivatives as lower homologues of selective agonists for neuronal alpha-7 nicotinic acetylcholine receptor subtypes 195
M2 muscarinic receptor agonists interfere with the cell proliferation and survival of human glioblastoma cancer stem cells 194
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 192
Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation 192
Nicotinic anti-inflammatory pathway: a new target to control low-grade inflammation and glucose homeostasis in obesity 190
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-Coupled Receptor 190
Alteration of the mitochondrial activity and lipidic metabolism caused by the selective stimulation of M2 muscarinic receptors in human glioblastoma cells 187
Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor 187
Activation of M2 muscarinic acetylcholine receptors by orthosteric and dualsteric agonists in glioblastoma cancer stem cells: effects on cell proliferation and drug resistance 187
Synthesis of enantiopure Delta(2)-isoxazoline derivatives and evaluation of their affinity and efficacy profiles at human beta-adrenergic receptor subtypes 184
Dualsteric activation of M2 muscarinic acetylcholine receptors inhibits cell proliferation in human glioblastoma cell lines 183
Lactam Enolate-Pyridone Addition : Synthesis of 4-Halocytisines 181
Targeting the D3R-nAChR heteromeric complex for nicotine cessation 178
Synthesis of novel epibatidine-related derivatives through 1,3-dipolar cycloaddition of pyridinenitrile oxides 178
Synthesis of new Delta(2)-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists 178
Novel quinuclidine derivatives to investigate the alpha-7 nicotinic acetylcholine receptor activation: new insight and perspectives 177
G protein inhibitors unravel Gq-dependent adenylyl cyclase activation in CHO-M1 cells 177
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation 176
Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human b-adrenergic receptor subtypes 174
Synthesis and pharmacological characterization of new analogs of broxaterol 174
M2-Receptor Stimulation in Blood-Brain-Tumour Barrier: Implications in Glioblastoma Therapy 173
Selective nicotinic agonists to treat pathologies of the central nervous system 172
Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells 172
Novel bicylic delta2-isoxazoline and 3-oxo-isoxazolidine derivatives : synthesis and binding affinity at neuronal nicotinic receptor subtypes 171
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells 171
Nicotinic agonists selective for the Alpha7 Receptor Subtype, the process for their preparation thereof and pharmaceutical compositions therefrom 168
In vivo study of the role of α6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 165
Synthesis, characterization and in vitro evaluation of hybrid monomeric peptides suited for multimodal imaging by pet/oi: Extending the concept of charge–cell binding correlation 164
SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF STEREOISOMERIC MUSCARINES 163
In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ2-isoxazoline molecular skeleton 163
Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site 162
Progettazione e sintesi di analoghi strutturali dell’Epibossodina 161
New hybrid muscarinic agonists: in vitro functional characterization and in vivo analgesic activity evaluation 161
Novel Bifunctional Compounds Targeting Nicotine and Dopamine Receptor Subtypes: Synthesis and Pharmacological Investigation 161
Transdermal delivery of morphine derivatives : a qualitative structure/in vitro permeability relationship 159
Light-Activated Pharmacological Tools for Exploring the Cholinergic System 158
New Hybrid and Mutant PIA and MII Toxins with Greater Affinty and Selectivity for the A6* Subtype 158
A chemoenzymatic approach to the synthesis of the stereoisomers of a beta-adrenergic receptor antagonist 157
Pharmacological profile of enantiomerically pure chiral muscarinic agonists - Desoxymuscarines 157
Design, synthesis and pharmacological properties of alkylbisammonio bitopic ligands of muscarinic acetylcholine receptors 157
Totale 22.725
Categoria #
all - tutte 82.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 0 0 105
2021/20222.860 189 91 98 135 174 469 547 148 174 195 210 430
2022/20232.538 335 228 240 287 242 440 83 191 207 59 136 90
2023/20241.857 62 125 74 83 394 166 129 120 101 125 242 236
2024/20254.624 176 417 179 427 388 240 184 486 218 348 675 886
2025/20269.979 874 682 1.289 754 848 700 1.053 473 1.020 677 1.088 521
Totale 30.518